Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery

Pediatric Research

Volumn 74, Issue 4, 2013, Pages 413-419

  Davidson, Jesse ^a   Tong, Suhong ^b   Hauck, Amanda ^a   Lawson, D Scott ^a   Cruz, Eduardo Da ^a   Kaufman, Jon ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MALE; NEWBORN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; THORAX SURGERY;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CARDIOVASCULAR SURGICAL PROCEDURES; COHORT STUDIES; HUMANS; INFANT; INFANT, NEWBORN; KINETICS; LINEAR MODELS; LIVER FUNCTION TESTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84885642063     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.124     Document Type: Article

References (24)

1. Kaplan JM, Wong HR. Biomarker discovery and development in pediatric critical care medicine. Pediatr Crit Care Med 2011;12:165-73.
2. Raja SG, Dreyfus GD. Modulation of systemic infammatory response afer cardiac surgery. Asian Cardiovasc Torac Ann 2005;13:382-95. (Pubitemid 41824742)
3. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin afer cardiac surgery: a systematic review of the literature. Crit Care 2006;10:R145.
4. Arkader R, Troster EJ, Lopes MR, et al. Procalcitonin does discriminate between sepsis and systemic infammatory response syndrome. Arch Dis Child 2006;91:117-20. (Pubitemid 43372019)
5. McMaster P, Park DY, Shann F, et al. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection afer cardiopulmonary bypass in children. Pediatr Crit Care Med 2009;10:217-21.
6. Arkader R, Troster EJ, Abellan DM, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardio-thorac Vasc Anesth 2004;18:160-5. (Pubitemid 38506862)
7. Celebi S, Koner O, Menda F, et al. Procalcitonin kinetics in pediatric patients with systemic infammatory response afer open heart surgery. Intensive Care Med 2006;32:881-7. (Pubitemid 43781370)
8. Beghetti M, Rimensberger PC, Kalangos A, Habre W, Gervaix A. Kinetics of procalcitonin, interleukin 6 and C-reactive protein afer cardiopulmo-nary-bypass in children. Cardiol Young 2003;13:161-7. (Pubitemid 41630909)
9. Dahaba AA, Metzler H. Procalcitonin's role in the sepsis cascade. Is procal-citonin a sepsis marker or mediator? Minerva Anestesiol 2009;75:447-52.
10. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic infammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 2010;159:253-64.
11. Skrak P, Kovacikova L, Kunovsky P. Procalcitonin, neopterin and C-reac-tive protein afer pediatric cardiac surgery with cardiopulmonary bypass. Bratisl Lek Listy 2007;108:501-5.
12. Hammer S, Loef M, Reichenspurner H, et al. Efect of cardiopulmonary bypass on myocardial function, damage and infammation afer cardiac surgery in newborns and children. Torac Cardiovasc Surg 2001;49:349-54. (Pubitemid 34051867)
13. Séguéla PE, Joram N, Romefort B, et al. Procalcitonin as a marker of bacterial infection in children undergoing cardiac surgery with cardiopulmo-nary bypass. Cardiol Young 2011;21:392-9.
14. Nahum E, Schiller O, Livni G, Bitan S, Ashkenazi S, Dagan O. Procalcito-nin level as an aid for the diagnosis of bacterial infections following pediat-ric cardiac surgery. J Crit Care 2012;27:220.e11-6.
15. Michalik DE, Duncan B W, Mee RB, et al. Quantitative analysis of procalci-tonin afer pediatric cardiothoracic surgery. Cardiol Young 2006;16:48-53. (Pubitemid 43193155)
16. Davidson J, Tong S, Hancock H, Hauck A, da Cruz E, Kaufman J. Prospective validation of the vasoactive-inotropic score and correlation to short-term outcomes in neonates and infants afer cardiothoracic surgery. Intensive Care Med 2012;38:1184-90.
17. Gaies MG, Gurney JG, Yen AH, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants afer cardiopulmonary bypass. Pediatr Crit Care Med 2010;11:234-8.
18. Mofdi R, Suttie SA, Patil PV, Ogston S, Parks RW. Te value of procalci-tonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 2009;146:72-81.
19. Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 2011;37:549-58.
20. Tang H, Huang T, Jing J, Shen H, Cui W. Efect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analy-sis. Infection 2009;37:497-507.
21. Nahum E, Livni G, Schiller O, Bitan S, Ashkenazi S, Dagan O. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children afer cardiac surgery. J Intensive Care Med 2012;27:191-6.
22. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008;29:328-33. (Pubitemid 351271703)
23. Stammet P, Devaux Y, Azuaje F, et al. Assessment of procalcitonin to predict outcome in hypothermia-treated patients afer cardiac arrest. Crit Care Res Pract 2011;2011:631062.
24. Los Arcos M, Rey C, Concha A, Medina A, Prieto B. Acute-phase reactants afer paediatric cardiac arrest. Procalcitonin as marker of immediate outcome. BMC Pediatr 2008;8:18.